血管活性性腸内ペプチドは,Rab13/PKA信号複合体を通じた状網の緊密な結合を調節することにより,眼高血圧を低下させる
Liwen Chen1, Xiaoqin Yan1, Zhaoxia Luo1
1Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Annals of medicine
|August 27, 2025
まとめ
血管活性性腸内ペプチド (VIP) は,Rab13- PKA経路経由で状網 (TM) の緊密結節 (TJ) を阻害することで,高眼圧 (IOP) を低下させ,眼高血圧に対する新しい治療の洞察をもたらします.
科学分野:
- 眼科について
- 細胞生物学
- 生理学
背景:
- シュレム管とトラベキュラーメッシュ (TM) は,眼内圧 (IOP) ホメオスタシスの維持に重要な役割を果たします.
- 血管活性性腸内ペプチド (VIP) は,以前,シュレム管内皮のF-アクチンに影響することで,高血圧を低下させる可能性を示していた.
- この研究では,VIPのメカニズムをTM 緊密な交差点 (TJ) で調査しています.
研究 の 目的:
- VIPがTMの緊密な接点に影響を与えるメカニズムを解明する.
- TMによる眼高血圧の調節におけるVIPの役割を決定する.
- TMに対するVIPの影響におけるRab13-PKA信号経路を調査する.
主な方法:
- ネズミとヒトの状網細胞 (HTMC) の高いIOPモデルが確立されています.
- H&E染色を用いてTonoLabとTM組織密度を評価した.
- ZO-1,クラウジン-1,Rab13,PKA発現を分析するために,ウエスタン・ブロッティング,qRT-PCR,免疫光,および免疫ヒスト化学を用いた.
主要な成果:
- 高血圧モデルにおけるTJタンパク質ZO- 1とClaudin- 1の発現増加
- VIPとRab13の過剰発現は,圧力刺激によるHTMCにおいてZO-1とClaudin-1を減少させた.
- VIPはTJタンパク質とTM密度を低下させ,眼高血圧を緩和した.
結論:
- VIPは,Rab13-PKA信号複合体を調節することによって,TM緊密な結合を阻害する.
- このメカニズムはネズミの眼高血圧を効果的に低下させる.
- この発見は,眼高血圧の治療のための新しい治療戦略を提供します.
関連する概念動画
01:27Open Angle Glaucoma: Treatment
561
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
561
01:29Tight Junctions
5.5K
Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
5.5K
01:25Glaucoma: Overview
749
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
749
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
875
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
875
01:45Endocrine Signaling
64.9K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
64.9K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
915
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
915